Citigroup Portfolio holdings
Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$436M |
| 2 |
United Therapeutics
UTHR
|
+$393M |
| 3 |
Amazon
AMZN
|
+$376M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$372M |
| 5 |
Visa
V
|
+$364M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI EAFE ETF
EFA
|
+$313M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$272M |
| 3 |
Stellantis
STLA
|
+$222M |
| 4 |
TSMC
TSM
|
+$215M |
| 5 |
Bank of America
BAC
|
+$184M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.76% |
| 2 | Consumer Discretionary | 6.77% |
| 3 | Healthcare | 6.2% |
| 4 | Financials | 5.48% |
| 5 | Communication Services | 4.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2576
Kadant
KAI
$3.63B
| $1.35M | ﹤0.01% |
4,610
-30,972
| -87% | -$8.83M |
|
2577
Axsome Therapeutics
AXSM
$12.1B
| $1.35M | ﹤0.01% |
16,798
-78,274
| -82% | -$5.8M |
|
2578
PUT
Ring Energy
REI
$315M
| $1.35M | ﹤0.01% |
800,000
| – | – |
|
2579
NeoGenomics
NEO
$2.04B
| $1.35M | ﹤0.01% |
97,166
+6,996
| +8% | +$99.2K |
|
2580
NCR Voyix
VYX
$1.12B
| $1.35M | ﹤0.01% |
109,122
-259,475
| -70% | -$3.27M |
|
2581
Kyndryl
KD
$2.98B
| $1.34M | ﹤0.01% |
51,065
+27,598
| +118% | +$662K |
|
|
PENG
2582
Penguin Solutions Inc
PENG
$2.64B
| $1.34M | ﹤0.01% |
58,710
+8,298
| +16% | +$173K |
|
2583
La-Z-Boy
LZB
$1.61B
| $1.34M | ﹤0.01% |
35,950
+2,184
| +6% | +$77.1K |
|
2584
Constellium
CSTM
$3.89B
| $1.34M | ﹤0.01% |
71,089
+45,104
| +174% | +$938K |
|
|
AY
2585
DELISTED
Atlantica Sustainable Infrastructure plc Ordinary Shares
AY
| $1.34M | ﹤0.01% |
61,038
-149,971
| -71% | -$3.14M |
|
2586
Melco Resorts & Entertainment
MLCO
$2.24B
| $1.34M | ﹤0.01% |
179,499
+15,620
| +10% | +$118K |
|
2587
Invesco Aerospace & Defense ETF
PPA
$8.15B
| $1.34M | ﹤0.01% |
13,030
+59
| +0.5% | +$6.05K |
|
2588
Twist Bioscience
TWST
$5.69B
| $1.34M | ﹤0.01% |
27,138
-197,969
| -88% | -$8.07M |
|
|
SWTX
2589
DELISTED
SpringWorks Therapeutics
SWTX
| $1.34M | ﹤0.01% |
35,495
-128,050
| -78% | -$5.39M |
|
|
AMWD
2590
DELISTED
American Woodmark
AMWD
| $1.34M | ﹤0.01% |
17,003
+931
| +6% | +$84K |
|
2591
Orion
OEC
$381M
| $1.34M | ﹤0.01% |
60,913
+7,154
| +13% | +$172K |
|
|
DEA
2592
Easterly Government Properties
DEA
$1.15B
| $1.33M | ﹤0.01% |
43,127
+4,226
| +11% | +$125K |
|
|
GTM
2593
ZoomInfo Technologies
GTM
$978M
| $1.33M | ﹤0.01% |
104,402
-30,238
| -22% | -$423K |
|
2594
CALL
TG Therapeutics
TGTX
$8.19B
| $1.33M | ﹤0.01% |
74,900
+35,000
| +88% | +$558K |
|
|
2595
PUT
TG Therapeutics
TGTX
$8.19B
| $1.33M | ﹤0.01% |
74,900
+35,000
| +88% | +$558K |
|
2596
iShares MSCI Switzerland ETF
EWL
$2.21B
| $1.33M | ﹤0.01% |
27,635
-8,438
| -23% | -$402K |
|
2597
Dime Commercial Bancshares
DCOM
$1.8B
| $1.33M | ﹤0.01% |
65,138
-2,868
| -4% | -$54.1K |
|
2598
Evercore
EVR
$12.1B
| $1.33M | ﹤0.01% |
6,373
+1,738
| +37% | +$338K |
|
|
2599
TG Therapeutics
TGTX
$8.19B
| $1.33M | ﹤0.01% |
74,547
-454,022
| -86% | -$7.24M |
|
|
OPLN
2600
Openlane
OPLN
$4.29B
| $1.32M | ﹤0.01% |
79,865
+7,878
| +11% | +$135K |
|
Similar funds
Citigroup's Q2 2024 Portfolio in Review
As of Q2 2024, Citigroup held 5,888 positions worth $156B, up 2.5% from $152B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Citigroup's Q2 2024 filing shows 274 new, 2,819 increased, 1,798 reduced and 330 closed positions. Its largest new stake was Ferrovial N.V. Ordinary Shares: 8,935,948 shares worth $344M. The largest sale was iShares MSCI EAFE ETF, an estimated $313M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- Citigroup's largest Q2 2024 buy was Ferrovial N.V. Ordinary Shares: 8,935,948 shares worth $344M.
- Citigroup added most to Intel in Q2 2024, an estimated $436M increase.
- Citigroup's biggest Q2 2024 reduction was iShares MSCI EAFE ETF, cutting an estimated $313M.
- Citigroup fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $79.7M.
- Citigroup's ten largest holdings make up 22% of its $156B portfolio in Q2 2024.
- Citigroup opened 274 new positions and closed 330 in Q2 2024.
- Citigroup's portfolio value rose 2.5% quarter-over-quarter to $156B.
Based on Citigroup's 13F filing for Q2 2024, filed 12 Aug 2024.